 Bennett Davenport
Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chikungunya virus | 12 | 2025 | 76 | 2.400 |
Why?
| | CD8-Positive T-Lymphocytes | 8 | 2021 | 857 | 2.120 |
Why?
| | Chikungunya Fever | 11 | 2025 | 76 | 1.980 |
Why?
| | Immunologic Memory | 5 | 2020 | 349 | 1.770 |
Why?
| | Lymphocytic choriomeningitis virus | 4 | 2019 | 24 | 1.390 |
Why?
| | Chemokines | 4 | 2020 | 226 | 0.880 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2021 | 186 | 0.870 |
Why?
| | Lymph Nodes | 5 | 2024 | 470 | 0.850 |
Why?
| | Lymphocytic Choriomeningitis | 2 | 2018 | 14 | 0.710 |
Why?
| | Arenaviridae Infections | 2 | 2019 | 8 | 0.700 |
Why?
| | CD4-Positive T-Lymphocytes | 4 | 2020 | 1056 | 0.680 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 108 | 0.670 |
Why?
| | Alphavirus Infections | 4 | 2021 | 44 | 0.650 |
Why?
| | Joints | 1 | 2020 | 101 | 0.630 |
Why?
| | Aging | 2 | 2019 | 1774 | 0.620 |
Why?
| | Leishmania major | 1 | 2018 | 8 | 0.610 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 10 | 0.610 |
Why?
| | Mental Recall | 1 | 2019 | 191 | 0.590 |
Why?
| | Viral Envelope Proteins | 3 | 2025 | 81 | 0.570 |
Why?
| | Virulence Factors | 1 | 2018 | 156 | 0.550 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 342 | 0.510 |
Why?
| | Cytokines | 3 | 2020 | 2013 | 0.500 |
Why?
| | Mice | 21 | 2024 | 16915 | 0.450 |
Why?
| | Phagocytes | 2 | 2025 | 97 | 0.430 |
Why?
| | Animals | 30 | 2025 | 35309 | 0.430 |
Why?
| | Viremia | 2 | 2025 | 131 | 0.390 |
Why?
| | Antiviral Agents | 3 | 2025 | 712 | 0.390 |
Why?
| | Macrophages | 2 | 2022 | 1484 | 0.380 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 5439 | 0.370 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 24 | 0.350 |
Why?
| | Antibodies, Viral | 3 | 2025 | 601 | 0.340 |
Why?
| | Adaptive Immunity | 3 | 2020 | 161 | 0.330 |
Why?
| | Receptors, Immunologic | 2 | 2021 | 216 | 0.320 |
Why?
| | Mice, Knockout | 6 | 2022 | 2871 | 0.300 |
Why?
| | Mice, Inbred BALB C | 3 | 2020 | 1247 | 0.300 |
Why?
| | Peromyscus | 2 | 2004 | 28 | 0.280 |
Why?
| | Insulin-Secreting Cells | 2 | 2022 | 364 | 0.250 |
Why?
| | Antibodies, Neutralizing | 2 | 2025 | 265 | 0.240 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4057 | 0.240 |
Why?
| | Cysteine Proteases | 1 | 2025 | 5 | 0.240 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2025 | 50 | 0.240 |
Why?
| | Clodronic Acid | 1 | 2025 | 12 | 0.240 |
Why?
| | Molecular Probes | 1 | 2025 | 37 | 0.240 |
Why?
| | Immune Evasion | 1 | 2025 | 56 | 0.230 |
Why?
| | Mice, Transgenic | 6 | 2021 | 2117 | 0.220 |
Why?
| | Immunization | 3 | 2024 | 411 | 0.220 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 3 | 2014 | 336 | 0.220 |
Why?
| | Virulence | 3 | 2021 | 255 | 0.220 |
Why?
| | NADPH Oxidases | 1 | 2024 | 108 | 0.210 |
Why?
| | Ross River virus | 2 | 2021 | 23 | 0.210 |
Why?
| | Liposomes | 1 | 2025 | 171 | 0.210 |
Why?
| | Methionine | 1 | 2024 | 156 | 0.210 |
Why?
| | Kupffer Cells | 2 | 2021 | 49 | 0.210 |
Why?
| | Interferon Type I | 2 | 2021 | 139 | 0.200 |
Why?
| | Lectins, C-Type | 2 | 2020 | 71 | 0.200 |
Why?
| | Lymphoid Tissue | 2 | 2019 | 67 | 0.200 |
Why?
| | Salmonella | 1 | 2022 | 58 | 0.190 |
Why?
| | Viral Vaccines | 1 | 2022 | 94 | 0.180 |
Why?
| | Virus Replication | 2 | 2022 | 450 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2021 | 399 | 0.170 |
Why?
| | Proteome | 1 | 2025 | 438 | 0.170 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 9 | 0.170 |
Why?
| | Transcriptional Activation | 1 | 2022 | 367 | 0.170 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2537 | 0.170 |
Why?
| | O'nyong-nyong Virus | 1 | 2019 | 4 | 0.170 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 26 | 0.160 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2022 | 323 | 0.160 |
Why?
| | Adoptive Transfer | 1 | 2020 | 218 | 0.160 |
Why?
| | Arthritis | 1 | 2020 | 90 | 0.160 |
Why?
| | Parasite Load | 1 | 2018 | 8 | 0.150 |
Why?
| | Leishmania donovani | 1 | 2018 | 7 | 0.150 |
Why?
| | Gene Deletion | 2 | 2018 | 380 | 0.150 |
Why?
| | Antigens, Viral | 1 | 2018 | 178 | 0.140 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 79 | 0.140 |
Why?
| | Acute Disease | 1 | 2020 | 978 | 0.140 |
Why?
| | Nuclear Proteins | 2 | 2022 | 659 | 0.140 |
Why?
| | Dendritic Cells | 1 | 2021 | 479 | 0.140 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2019 | 756 | 0.140 |
Why?
| | Cells, Cultured | 4 | 2018 | 4077 | 0.140 |
Why?
| | Glucose | 2 | 2022 | 1001 | 0.130 |
Why?
| | Oxidative Stress | 2 | 2022 | 1266 | 0.130 |
Why?
| | TRPM Cation Channels | 2 | 2008 | 77 | 0.130 |
Why?
| | Bacterial Proteins | 1 | 2022 | 833 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 2 | 2011 | 412 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2022 | 1117 | 0.130 |
Why?
| | Cell Survival | 1 | 2018 | 1075 | 0.120 |
Why?
| | Monocytes | 1 | 2017 | 551 | 0.120 |
Why?
| | Chronic Disease | 1 | 2020 | 1716 | 0.110 |
Why?
| | Acute Lung Injury | 1 | 2017 | 279 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 704 | 0.110 |
Why?
| | Cell Movement | 1 | 2018 | 944 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1367 | 0.100 |
Why?
| | Vaccination | 1 | 2021 | 1347 | 0.100 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2013 | 169 | 0.100 |
Why?
| | Neutrophils | 1 | 2017 | 1207 | 0.090 |
Why?
| | Male | 6 | 2020 | 63512 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2017 | 1063 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 676 | 0.090 |
Why?
| | Transcription Factors | 1 | 2018 | 1647 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1613 | 0.080 |
Why?
| | Epitopes | 2 | 2025 | 470 | 0.080 |
Why?
| | T-Lymphocytes | 3 | 2019 | 1933 | 0.080 |
Why?
| | Immunodominant Epitopes | 1 | 2009 | 28 | 0.080 |
Why?
| | Parkinsonian Disorders | 1 | 2008 | 35 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2008 | 99 | 0.070 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2008 | 68 | 0.070 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 1109 | 0.070 |
Why?
| | Humans | 17 | 2025 | 129266 | 0.070 |
Why?
| | Viral Load | 2 | 2021 | 448 | 0.070 |
Why?
| | Endothelial Cells | 2 | 2024 | 746 | 0.070 |
Why?
| | RNA, Viral | 2 | 2021 | 619 | 0.070 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 147 | 0.070 |
Why?
| | Cloning, Molecular | 2 | 2004 | 525 | 0.070 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 427 | 0.060 |
Why?
| | Orthobunyavirus | 1 | 2025 | 2 | 0.060 |
Why?
| | Bunyaviridae Infections | 1 | 2025 | 8 | 0.060 |
Why?
| | Cysteine Endopeptidases | 1 | 2025 | 68 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2009 | 692 | 0.060 |
Why?
| | Hemocyanins | 1 | 2004 | 62 | 0.060 |
Why?
| | Immune Sera | 1 | 2004 | 87 | 0.060 |
Why?
| | Lung | 1 | 2017 | 3927 | 0.060 |
Why?
| | Mutation | 3 | 2025 | 3710 | 0.060 |
Why?
| | Sulfones | 1 | 2025 | 108 | 0.060 |
Why?
| | Antigen-Presenting Cells | 1 | 2004 | 151 | 0.060 |
Why?
| | Insulin | 2 | 2018 | 2325 | 0.060 |
Why?
| | Anaerobiosis | 1 | 2024 | 57 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2004 | 135 | 0.050 |
Why?
| | B-Lymphocytes | 2 | 2019 | 815 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2004 | 302 | 0.050 |
Why?
| | Antigen Presentation | 1 | 2004 | 207 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 191 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2004 | 437 | 0.050 |
Why?
| | Female | 3 | 2020 | 68551 | 0.050 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 363 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2023 | 223 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 174 | 0.050 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2022 | 55 | 0.050 |
Why?
| | Interferon Regulatory Factors | 1 | 2022 | 33 | 0.050 |
Why?
| | Phenylalanine | 1 | 2022 | 65 | 0.050 |
Why?
| | Feedback | 1 | 2022 | 162 | 0.050 |
Why?
| | HeLa Cells | 1 | 2023 | 611 | 0.050 |
Why?
| | Alphavirus | 1 | 2021 | 20 | 0.050 |
Why?
| | Vaccines, Attenuated | 1 | 2022 | 125 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3202 | 0.050 |
Why?
| | Amino Acids | 1 | 2025 | 486 | 0.050 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 297 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2018 | 2375 | 0.040 |
Why?
| | Protein Domains | 1 | 2022 | 253 | 0.040 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 58 | 0.040 |
Why?
| | Viral Tropism | 1 | 2019 | 29 | 0.040 |
Why?
| | Cricetinae | 1 | 2020 | 278 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 596 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 275 | 0.040 |
Why?
| | Venules | 1 | 2018 | 14 | 0.040 |
Why?
| | Chemokine CCL21 | 1 | 2018 | 14 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 349 | 0.040 |
Why?
| | Organelle Biogenesis | 1 | 2018 | 15 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 351 | 0.040 |
Why?
| | Conserved Sequence | 2 | 2009 | 227 | 0.040 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2017 | 5 | 0.040 |
Why?
| | Ovalbumin | 1 | 2018 | 178 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 74 | 0.040 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2017 | 17 | 0.040 |
Why?
| | Stromal Cells | 1 | 2018 | 105 | 0.040 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2017 | 15 | 0.040 |
Why?
| | Mitochondrial Dynamics | 1 | 2018 | 37 | 0.040 |
Why?
| | Antigens, Ly | 1 | 2017 | 44 | 0.040 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 39 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 23 | 0.040 |
Why?
| | Spleen | 1 | 2019 | 506 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 317 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2017 | 64 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 94 | 0.030 |
Why?
| | Luminescent Proteins | 1 | 2018 | 174 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 286 | 0.030 |
Why?
| | Protein Subunits | 1 | 2018 | 234 | 0.030 |
Why?
| | Cadaver | 1 | 2018 | 306 | 0.030 |
Why?
| | Magnesium | 2 | 2008 | 153 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 42 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 316 | 0.030 |
Why?
| | Granzymes | 1 | 2016 | 47 | 0.030 |
Why?
| | RNA Interference | 1 | 2018 | 450 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 220 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 300 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 648 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2018 | 672 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2021 | 803 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 181 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| | Cell Membrane | 2 | 2008 | 733 | 0.030 |
Why?
| | Nanoparticles | 1 | 2017 | 375 | 0.030 |
Why?
| | Thymus Gland | 1 | 2014 | 308 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2008 | 2056 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 3628 | 0.020 |
Why?
| | B7-2 Antigen | 1 | 2011 | 27 | 0.020 |
Why?
| | Viruses | 1 | 2013 | 100 | 0.020 |
Why?
| | CD28 Antigens | 1 | 2011 | 48 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2011 | 61 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2835 | 0.020 |
Why?
| | Pneumonia | 1 | 2017 | 616 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 874 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5482 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2009 | 51 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1155 | 0.020 |
Why?
| | Amino Acids, Diamino | 1 | 2008 | 1 | 0.020 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2008 | 7 | 0.020 |
Why?
| | Guam | 1 | 2008 | 7 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2009 | 57 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1887 | 0.020 |
Why?
| | Hybridomas | 1 | 2009 | 235 | 0.020 |
Why?
| | Ion Channel Gating | 1 | 2008 | 94 | 0.020 |
Why?
| | Proline | 1 | 2008 | 76 | 0.020 |
Why?
| | Leucine | 1 | 2008 | 108 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4926 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 588 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2008 | 318 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2737 | 0.020 |
Why?
| | Bacteria | 1 | 2013 | 813 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2008 | 250 | 0.020 |
Why?
| | Autoantigens | 1 | 2009 | 419 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2005 | 63 | 0.020 |
Why?
| | Temperature | 1 | 2008 | 634 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2008 | 464 | 0.010 |
Why?
| | Cell Division | 1 | 2005 | 796 | 0.010 |
Why?
| | Models, Molecular | 1 | 2008 | 1487 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 271 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 332 | 0.010 |
Why?
| | Protein Binding | 1 | 2009 | 2120 | 0.010 |
Why?
| | Calcium | 1 | 2008 | 1212 | 0.010 |
Why?
| | Interleukins | 1 | 2004 | 241 | 0.010 |
Why?
| | Homeostasis | 1 | 2005 | 605 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 947 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1710 | 0.010 |
Why?
| | Cell Line | 1 | 2005 | 2779 | 0.010 |
Why?
|
|
Davenport's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|